Clorox Co stock (US18539C2044): CEO transition and valuation metrics in focus

Clorox Co shares traded lower in New York after the United States household-products group said its board has started a comprehensive search for a new chief executive, following Chair and CEO Linda Rendle’s decision to step down for health reasons, sharpening investor attention on leadership continuity and the stock’s current valuation metrics.Clorox IR as of 04/29/2026

According to market data, the stock recently changed hands around USD 96 on the New York Stock Exchange under the ticker CLX, down roughly 4% in one of the latest sessions with volume around 2 million shares, valuing Clorox at about USD 11.6 billion and leaving the shares lower over the past 12 months.MarketBeat as of 05/29/2026

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

Clorox Co: core business model

Clorox Co focuses on branded consumer and professional products, with revenue largely generated from cleaning, household and lifestyle categories sold through retail and institutional channels.

Recent corporate actions

On 04/29/2026, Clorox announced that Chair and CEO Linda Rendle had asked the board to begin a comprehensive process to identify her successor as she plans to step down for health reasons, with Rendle expected to remain in her roles until a new chief executive is in place and potentially as chair for a transition period.Clorox IR as of 04/29/2026

The company stated that the board’s search will consider both internal and external candidates, indicating a structured succession approach at the United States issuer, while an accompanying Form 8-K filed with the US Securities and Exchange Commission provided formal notice of the leadership transition and referenced Rendle’s health-related reasons for the planned change.SEC Form 8-K as of 04/29/2026

Valuation metrics and multiples for Clorox Co

Valuation metrics for Clorox Co have come back into focus as investors weigh the leadership transition against fundamentals, with one data provider citing a trailing price-earnings ratio near 15.6 based on recent figures, below some historical levels for the stock but still reflecting a typical consumer-staples premium to the broader market in certain periods.GuruFocus as of 05/29/2026

The same valuation overview pointed to a composite scoring framework that assigned Clorox a GF Score of 75 out of 100, summarizing profitability, growth, financial strength and valuation metrics in a single indicator, while market price data over the last 12 months showed a decline of more than 20% and a year-to-date performance modestly negative as of late May 2026, underscoring how multiples have adjusted alongside the share-price trend.MarketBeat as of 05/29/2026

Conclusion

The announcement that Clorox Co’s board is launching a search for a new chief executive following Linda Rendle’s health-related decision to step down has placed management succession at the center of the investment narrative for the United States-based consumer-products company. With the shares trading below prior-year levels and valuation indicators such as the price-earnings ratio and composite scores adjusting alongside the stock’s retreat, investors now appear to be weighing how the eventual CEO appointment and any accompanying strategic signals may intersect with the current multiples. Against this backdrop, the NYSE-listed stock is likely to remain sensitive to updates on the leadership search and to future data points that could affect how the market prices Clorox Co within the consumer-staples universe.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.